|
TLK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.221350E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.338000E-02 |
| Normal-vs-Stage2 |
2.847600E-01 |
| Normal-vs-Stage3 |
1.284850E-01 |
| Normal-vs-Stage4 |
2.426200E-01 |
| Stage1-vs-Stage2 |
8.552200E-01 |
| Stage1-vs-Stage3 |
9.852200E-01 |
| Stage1-vs-Stage4 |
4.515400E-01 |
| Stage2-vs-Stage3 |
8.506000E-01 |
| Stage2-vs-Stage4 |
4.269800E-01 |
| Stage3-vs-Stage4 |
4.641000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.901350E-03 |
| Normal-vs-AfricanAmerican |
8.014000E-02 |
| Normal-vs-Asian |
2.871400E-01 |
| Caucasian-vs-AfricanAmerican |
3.333800E-01 |
| Caucasian-vs-Asian |
8.743000E-01 |
| AfricanAmerican-vs-Asian |
5.633800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.816410E-02 |
| Normal-vs-Female |
9.80609999999826E-05 |
| Male-vs-Female |
3.565900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.564300E-02 |
| Normal-vs-Extreme_Weight |
1.830840E-01 |
| Normal-vs-Obese |
2.334300E-02 |
| Normal-vs-Extreme_Obese |
8.130000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.509400E-01 |
| Normal_Weight-vs-Obese |
8.644600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.748600E-01 |
| Extreme_Weight-vs-Obese |
4.574600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.957000E-01 |
| Obese-vs-Extreme_Obese |
3.680400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.796800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.641720E-04 |
| Normal-vs-Age(61-80Yrs) |
2.236400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.071400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.004500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.12099999999937E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.697650E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.916700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.750000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.346200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.432300E-04 |
| Normal-VS-Type2 PRCC |
5.025400E-01 |
| Normal-VS-KIRP CIMP |
5.904500E-03 |
| Normal-VS-Unclassified PRCC |
8.324200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.556200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.288100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.147600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.815800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.935400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.177550E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.619200E-01 |
| Normal-vs-N1 |
1.078010E-02 |
| Normal-vs-N2 |
2.859400E-01 |
| N0-vs-N1 |
1.664220E-02 |
| N0-vs-N2 |
1.941180E-01 |
| N1-vs-N2 |
7.113000E-01 |
|
|
